Clinical Trials

By taking part in a clinical trial at UAB, you can play a vital role in UAB's internationally renowned research enterprise. 

Trials currently available at UAB are listed below; click the tags to refine the list.

addiction adolescents adults aging bioenergetic health and health behavior black blood pressure brain and spinal cord health cancer caregiving children chronic illness covid19 dental health diabetes driving and pedestrian safety exercise nutrition and weight loss eye health gastroenterology and hepatology genetics and genomics healthy heart health hiv aids infectious diseases and immunology kidney health lgbtq lung health men mental health and psychiatry neurology orthopaedics physical medicine rehabilitation and pain rheumatology sexual health sleep health urology urogynecology gynecology and obstetrics white women
April 30, 2024

Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Semaglutide Once Weekly in Adult Participants with Type 2 Diabetes

A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Semaglutide Once Weekly in Adult Participants with Type 2 Diabetes and Inadequate Glycemic Control with Metformin with or without SGLT2 Inhibitor (TRANSCEND-T2D-2)

TRANSCEND-T2D-2 is a clinical research study for people with type 2 diabetes.
This study will test if an investigational medicine (the medicine being studied) can
help with blood glucose (sugar) and weight management compared with an existing
treatment for type 2 diabetes.

  • Are aged 18 years or older
  • Have type 2 diabetes
  • Have been taking 1500mg or more of metformin each day for at least 3 months (with or without SGLT2i)
  • Have a BMI of 25 or more
  • Have HbA1c levels of 7.0% to 10.5%

To see if you qualify please contact at 205-996-4015, 205-934-5564 or via mail at tthoma@uab.edu or ccnrn@uab.edu
Published in Clinical Trials
back to top